Last update 15 May 2025

ASKG-915

Overview

Basic Info

Drug Type
Fusion protein
Synonyms
ASKG 915, ASKG915
Target
IL15R x PD-1
Action
modulators, inhibitors
Mechanism
Interleukin-15 receptors modulators(Interleukin-15 receptors modulators), PD-1 inhibitors(Programmed cell death protein 1 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced cancerAdvanced Malignant Solid NeoplasmMetastatic Solid Tumor+ [1]
Inactive Indication-
Originator Organization
AskGene Pharma, Inc.AskGene Pharma, Inc.
Active Organization
Jiangsu Aosaikang Biomedicine Co., Ltd.Jiangsu Aosaikang Biomedicine Co., Ltd.AskGene Pharma, Inc.AskGene Pharma, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ASKG-915
NCT05867420
/ RecruitingPhase 1
A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASKG915 as a Single Agent in Patients With Selected Advanced Solid Tumors.
100 Clinical Results associated with ASKG-915
Login to view more data
100 Translational Medicine associated with ASKG-915
Login to view more data
100 Patents (Medical) associated with ASKG-915
Login to view more data
100 Deals associated with ASKG-915
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 1
United States
Jiangsu Aosaikang Biomedicine Co., Ltd.Jiangsu Aosaikang Biomedicine Co., Ltd.
02 Aug 2023
Advanced Malignant Solid NeoplasmPhase 1
United States
Jiangsu Aosaikang Biomedicine Co., Ltd.Jiangsu Aosaikang Biomedicine Co., Ltd.
02 Aug 2023
Metastatic Solid TumorIND Approval
China
Jiangsu Aosaikang Biomedicine Co., Ltd.Jiangsu Aosaikang Biomedicine Co., Ltd.
08 Apr 2025
Unresectable Solid NeoplasmIND Approval
China
Jiangsu Aosaikang Biomedicine Co., Ltd.Jiangsu Aosaikang Biomedicine Co., Ltd.
08 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free